Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors

Prenatal Diagnosis

Volumn 32, Issue 13, 2012, Pages 1225-1232

  Dan, Shan ^a,b   Wang, Wei ^a   Ren, Jinghui ^c   Li, Yali ^d   Hu, Hua ^e   Xu, Zhengfeng ^f   Lau, Tze Kin ^g   Xie, Jianhong ^h   Zhao, Weihua ⁱ   Huang, Hefeng ^j,k   Xie, Jiansheng ^l   Sun, Luming ^m   Zhang, Xiaohong ⁿ   Wang, Weipeng ^o   Liao, Shixiu ^p   Qiang, Rong ^q   Cao, Jiangxia ^r   Zhang, Qiufang ^s   Zhou, Yulin ^t   Zhu, Haiyan ^u   Zhong, Mei ^v   Guo, Yi ^w   Lin, Linhua ^c   Gao, Zhiying ^d   Yao, Hong ^e   Zhang, Hongyun ^a   Zhao, Lijian ^a   Jiang, Fuman ^a   Chen, Fang ^a   Jiang, Hui ^a   Li, Songgang ^a   Li, Yingrui ^a   Wang, Jun ^a   Wang, Jian ^a   Duan, Tao ^m   Su, Yue ^b   Zhang, Xiuqing ^a   more..

^a BGI SHENZHEN   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SHENZHEN PEOPLE'S HOSPITAL   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e THIRD MILITARY MEDICAL UNIVERSITY   (China)

^f NANJING MEDICAL UNIVERSITY   (China)

^g Fetal Medicine Centre   (Hong Kong)

^h Zhuhai Municipal Maternal and Child Healthcare Hospital   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^j ZHEJIANG UNIVERSITY   (China)

^k ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^l Shenzhen Key Laboratory for Birth Defects Prevention and Control   (China)

^m TONGJI UNIVERSITY   (China)

ⁿ PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^o Hubei Maternal and Child Health Hospital   (China)

^p ZHENGZHOU UNIVERSITY   (China)

^q Maternal and Child Health Care Hospital of Shaanxi Province   (China)

^r Wuhan Medical Care Center for Women and Children   (China)

^s PEKING UNIVERSITY THIRD HOSPITAL   (China)

^t Xiamen Maternity and Child Health Care Hospital   (China)

^u MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^v FIRST MILITARY MEDICAL UNIVERSITY   (China)

^w Dalian Obstetrics and Gynecology Hospital ^*  (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS MONITORING; FOLLOW UP; GENETIC COUNSELING; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MASSIVELY PARALLEL SEQUENCING; MATERNAL PLASMA; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TRISOMY 18; TRISOMY 21;

ADOLESCENT; ADULT; CHINA; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TRISOMY; WORKFLOW; YOUNG ADULT;

EID: 84870688045     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4002     Document Type: Article

References (38)

1. Statistics NBo. The population change of China in 2011 [WWW document]. URL http://www.gov.cn/gzdt/2012-01/18/content_2047892.htm [accessed on 18 January 2012].
2. Health CsMo. Report on Women and Children's Health Development in China [WWW document]. URL http://www.gov.cn/gzdt/2011-09/21/content_1952953.htm [accessed on 21 September 2011].
3. Dai L, Zhu J, Liang J, et al. Birth defects surveillance in China. World J Pediatr 2011;7:302-10.
4. Corrado F, Cannata ML, La Galia T, et al. Pregnancy outcome following mid-trimester amniocentesis. J Obstet Gynaecol 2012;32:117-9.
5. Enzensberger C, Pulvermacher C, Degenhardt J, et al. Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villus Sampling and Fetal Blood Sampling. Ultraschall Med 2012. [Epub ahead of print].
6. Kollmann M, Haeusler M, Haas J, et al. Procedure-Related Complications after Genetic Amniocentesis and Chorionic Villus Sampling. Ultraschall Med 2012. [Epub ahead of print].
7. Dhaifalah I, Dusek L, Santavy J. Implementation of One-Stop-Clinic for Risk Assessment of chromosomal abnormalities in the first trimester, evaluating the effectiveness and making it part of our daily practice. Ceska Gynekol 2011;76:292-306.
8. Ghaffari SR, Tahmasebpour AR, Jamal A, et al. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free beta-hCG and PAPP-A: a 5-year prospective study. Ultrasound Obstet Gynecol 2012;39:528-34.
9. Canick J. Prenatal screening for trisomy 21: recent advances and guidelines. Clin Chem Lab Med 2011; 50:1003-8.
10. Morris JK, Waters JJ, de Souza E. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008. Prenat Diagn 2012;32:596-601.
11. Majer S, Bauer M, Magnet E, et al. Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester. Prenat Diagn 2007;27:1219-23.
12. Devaney SA, Palomaki GE, Scott JA, et al. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306:627-36.
13. Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 2007;104:13116-21.
14. Tsui NB, Chiu RW, Ding C, et al. Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. Clin Chem 2005;51:2358-62.
15. Tong YK, Ding C, Chiu RW, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 2006;52:2194-202.
16. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-23.
17. Papageorgiou EA, Karagrigoriou A, Tsaliki E, et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011;17:510-3.
18. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-63.
19. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266-71.
20. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205 e1-11.
21. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
22. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
23. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:322 e1-5.
24. Chen EZ, Chiu RW, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6:e21791.
25. Lau TK, Chen F, Pan X, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012;25:1370-4.
26. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
27. Lau TK, Chan MK, Salome Lo PS, et al. Clinical utility of noninvasive fetal trisomy (NIFTY) test - early experience. J Matern Fetal Neonatal Med 2012;25(10):1856-9.
28. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
29. Aboussair N, Jaouad IC, Dequaqui SC, et al. Cytogenetic analysis of 5572 patients referred for suspected chromosomal abnormalities in morocco. Genet Test Mol Biomarkers 2012;16:569-73.
30. Mademont-Soler I, Morales C, Clusellas N, et al. Prenatal cytogenetic diagnosis in Spain: analysis and evaluation of the results obtained from amniotic fluid samples during the last decade. Eur J Obstet Gynecol Reprod Biol 2011;157:156-60.
31. Leung TY, Chan LW, Leung TN, et al. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007;29:14-7.
32. Deans Z, Newson AJ. Ethical considerations for choosing between possible models for using NIPD for aneuploidy detection. J Med Ethics 2012;38(10):614-8.
33. Phimister EG, Feero WG, Guttmacher AE. Realizing genomic medicine. N Engl J Med 2012;366:757-9.
34. Rothberg JM, Hinz W, Rearick TM, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011;475:348-52.
35. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of Microdeletion 22q11.2 in a Fetus by Next-Generation Sequencing of Maternal Plasma. Clin Chem 2012;58:1148-51.
36. Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2:61ra91.
37. Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012;4:137ra76.
38. Yan TZ, Mo QH, Cai R, et al. Reliable detection of paternal SNPs within deletion breakpoints for non-invasive prenatal exclusion of homozygous alpha-thalassemia in maternal plasma. PLoS One 2011;6:e24779.